ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13300; 2) Community: the network communities that were significantly associated with the response to NSC 13300; 3) Molecule: the relationships between components within communities and NSC 13300; 4) MDR: the compounds that were significantly associated with the NSC 13300.

NSC Compound Enrichment Correlation
NSC 698395 Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- 0.0246753314031139 0.27617869
NSC 702415 Null 0.0246753314031139 0.05855309
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0246753314031139 -0.18932713
NSC 722659 N-methylpiperazinoacetyl-partricin A dimethylaminoethylamide 0.0246753314031139 -0.031506003
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0246753314031139 0.012601788
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0246753314031139 0.066148574
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.0248868750898601 -0.034466503
NSC 401166 Null 0.0248868750898601 -0.055890029
NSC 606985 Camptothecin Derivative 0.0248868750898601 -0.031027647
NSC 615804 ANTINEOPLASTIC-615804 0.0248868750898601 -0.041971054
Total:57  Current:33    [First] [Prev] [Next] [Last]